CVSARRP: A framework to predict the risk of adverse to severe adverse reactions for 10855 diseases after COVID-19 vaccination

COVID-19 vaccines greatly reduce the risk of infection with SARS-CoV-2. However, some people have adverse reactions after vaccination, and these can sometimes be severe. Gender, age, vaccines, and especially certain diseases histories are related to severe adverse reactions following COVID-19 vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Jiahuan, Li, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041818/
https://www.ncbi.nlm.nih.gov/pubmed/37009244
http://dx.doi.org/10.1016/j.heliyon.2023.e14828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041818/
https://www.ncbi.nlm.nih.gov/pubmed/37009244
http://dx.doi.org/10.1016/j.heliyon.2023.e14828

Ejemplares similares